• Treg Cell
• Okadaic Acid
• Adaptive Immune System
• Peptide Inhibitor
• Promote Tumor Growth

Tumors progress in immunocompetent hosts despite the ability of the adaptive immune system to recognize cancer cells. Ion gradients regulate T cell function but their role in intratumoral immune responses is unexplored. We found that the concentration of K⁺ was strikingly elevated within tumors while the concentration of the divalent cations Ca²⁺ and Mg²⁺ was similar to serum levels. High K⁺ levels significantly blunted cytokine production and suppression TCR stimulation induced gene transcription in CD8⁺ and CD4⁺ effector T cells. Moreover, polarization of CD8⁺ and CD4⁺ T cells in high K⁺ suppressed effector differentiation and promoted the formation of CD4⁺ Foxp3⁺ T_reg cells. Surprisingly, this was not due to an attenuation of TCR induced Ca²⁺ flux, but rather to reduced activation of the serine/threonine Akt-mTOR pathway and could be partially reversed by overexpression of constitutively active Akt1. This coincided with the finding that okadaic acid, an inhibitor of the serine/threonine phosphatase PP2A, rendered effector cells resistant to the inhibitory effects of high K⁺ and restored cytokine function within tumors. Additionally, expression of a peptide inhibitor targeting the PP2A complex provided resistance to the inhibitory effect of elevated K⁺. These findings identify a novel mechanism of ionic regulation of TCR induced signals and immunosuppression within tumors whereby locally high extracellular concentrations of normally intracellular ions suppress immune function to promote tumor growth.